跳至主要内容
临床试验/NCT03463642
NCT03463642已完成不适用

The Efficacy of Different Vitamin D Supplementation Delivery Methods on Serum 25(OH)D in Humans a Randomised Double-blind Placebo Trial

University of Wolverhampton2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2017年2月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
2
主要终点
serum 25(OH)D

研究概览

简要总结

To test the efficacy of different vitamin D delivery methods on serum 25(OH)D. Participants randomly assigned to one of seven groups - three placebo groups and 4 active supplement groups receiving 100,000IU vitamin D3

详细描述

Various delivery methods of vitamin D supplementation are available to consumers but there have been no studies providing evidence of whether one delivery method is superior to others. The researchers wanted to compare the delivery of 100,000IU vitamin D3 by three methods on serum 25(OH)D levels. Two methods of oral supplementation (pill [prolonged release] and liquid [immediate release]), and delivery through the skin (with and without a penetrator enhancer. Placebo groups were pill, oral liquid and skin applied oil

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • healthy, female

排除标准

  • any participant that was taking vitamin supplementation, had a skin condition that would prevent them from applying oil to their skin or were taking, or had been taking in the past 6-months, oestrogen based contraception

研究组 & 干预措施

Vitamin D3 oral liquid

Experimental

100 drops = 100,000IU in orange syrup

干预措施: vitamin D3 (Dietary Supplement)

Vitamin D3 pill

Experimental

100 pills = 100,000IU + Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate

干预措施: Pill (Dietary Supplement)

Pill placebo

Placebo Comparator

100 pills = Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate

干预措施: Pill (Dietary Supplement)

Vitamin D3 pill

Experimental

100 pills = 100,000IU + Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate

干预措施: vitamin D3 (Dietary Supplement)

Vitamin D3 oral liquid

Experimental

100 drops = 100,000IU in orange syrup

干预措施: orange syrup (Dietary Supplement)

Oral liquid placebo

Placebo Comparator

100 drops orange syrup

干预措施: orange syrup (Dietary Supplement)

Skin oil + Vitamin D3 + penetrator

Experimental

100,000IU + mineral oil+ Tangerine essential oil (10ml)

干预措施: Penetrator (Dietary Supplement)

Skin oil placebo

Placebo Comparator

Skin application: 100ml of mineral oil coloured with food colourant to match active oil sample

干预措施: mineral oil (Other)

Skin oil + Vitamin D3

Experimental

100,000IU + mineral oil

干预措施: vitamin D3 (Dietary Supplement)

Skin oil + Vitamin D3

Experimental

100,000IU + mineral oil

干预措施: mineral oil (Other)

Skin oil + Vitamin D3 + penetrator

Experimental

100,000IU + mineral oil+ Tangerine essential oil (10ml)

干预措施: vitamin D3 (Dietary Supplement)

Skin oil + Vitamin D3 + penetrator

Experimental

100,000IU + mineral oil+ Tangerine essential oil (10ml)

干预措施: mineral oil (Other)

结局指标

主要结局

serum 25(OH)D

时间窗: 4 weeks

Changes in serum 25(OH)D levels

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew Wyon

Professor Matthew Wyon

University of Wolverhampton

研究点 (2)

Loading locations...

相似试验